Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial
RCT 260 patients in India, 130 treated with aspirin, promethazine, vitamin C, D, B3, zinc, and selenium, showing faster recovery with treatment. There was no hospitalization, ICU admission, or supplemental oxygen requirements in either group.
risk of no recovery, 89.2% lower, RR 0.11, p = 0.05, treatment 0 of 99 (0.0%), control 4 of 93 (4.3%), NNT 23, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, dyspnea.
|
risk of no recovery, 95.4% lower, RR 0.05, p < 0.001, treatment 0 of 99 (0.0%), control 10 of 93 (10.8%), NNT 9.3, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, anosmia.
|
risk of no recovery, 94.3% lower, RR 0.06, p = 0.003, treatment 0 of 99 (0.0%), control 8 of 93 (8.6%), NNT 12, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, fatigue.
|
risk of no recovery, 387.9% higher, RR 4.88, p = 0.50, treatment 2 of 99 (2.0%), control 0 of 93 (0.0%), continuity correction due to zero event (with reciprocal of the contrasting arm), day 10, myalgia.
|
risk of no recovery, 193.9% higher, RR 2.94, p = 1.00, treatment 1 of 99 (1.0%), control 0 of 93 (0.0%), continuity correction due to zero event (with reciprocal of the contrasting arm), day 10, headache.
|
risk of no recovery, 8.5% lower, RR 0.91, p = 0.66, treatment 37 of 99 (37.4%), control 38 of 93 (40.9%), NNT 29, day 10, cough.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|

Kumar et al., 30 May 2022, Randomized Controlled Trial, India, peer-reviewed, mean age 36.0, 8 authors, study period December 2021 - February 2022, this trial uses multiple treatments in the treatment arm (combined with aspirin, promethazine, vitamin C, D, B3, and selenium) - results of individual treatments may vary, trial
CTRI/2021/06/034254.
Contact:
vgvclinical@gmail.com.
Abstract: Open Access Original
Article
DOI: 10.7759/cureus.25467
Efficacy and Safety of Aspirin, Promethazine, and
Micronutrients for Rapid Clinical Recovery in
Mild to Moderate COVID-19 Patients: A
Randomized Controlled Clinical Trial
Review began 05/12/2022
Review ended 05/20/2022
Published 05/30/2022
© Copyright 2022
Kumar et al. This is an open access article
distributed under the terms of the Creative
Dr. G. Sunil Kumar 1 , Dr.Atul Vadgaonkar 2 , Dr. Srilata Purunaik 3 , Rohit Shelatkar 4 , Vidyadhar G. Vaidya
Sr. 5 , Dr. Gayatri Ganu 6 , Dr. Aditya Vadgaonkar 7 , Shashank Joshi 8
Commons Attribution License CC-BY 4.0.,
which permits unrestricted use, distribution,
and reproduction in any medium, provided
the original author and source are credited.
1. Cardiology, S K Clinic & Scans, Thiruvanathapuram, IND 2. General Medicine, Vijay Nursing Home, Nashik, IND 3.
Respiratory Medicine, Swasthi Orthopaedic and Respiratory Health Care, Bengaluru, IND 4. Pharmacology and
Therapeutics, Vitabiotics Ltd., London, GBR 5. General Surgery, Lokmanya Medical Research Centre, Pune, IND 6.
Pharmacology and Therapeutics, Mprex Healthcare Pvt. Ltd., Pune, IND 7. Medicine, King Edward Memorial Hospital
and Seth Gordhandas Sunderdas Medical College, Mumbai, IND 8. Endocrinology, Lilavati Hospital, Mumbai, IND
Corresponding author: Vidyadhar G. Vaidya Sr., vgvclinical@gmail.com
Abstract
kumar3
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit